Trent Timson
Podiatrist · McPherson, KSNPI 1033229448
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $661 of the $940 with a category attached, or 70.3%. 8 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 42.0% of the total. Reporting peaked in 2021 at $437 and has fallen 92.0% since, to $35 in 2025.
Across 28 payments — averaging $33.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$395
- Stryker$177
- Paratek Pharmaceuticals, Inc.$137
- Organogenesis Inc.$85
- Melinta Therapeutics, LLC$70
- Johnson & Johnson$45
- plus $32 from 2 others
What the payments were for
- Travel & lodging$27930%
- Food & beverage$66170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 4 | $395 |
| Stryker | 5 | $177 |
| Paratek Pharmaceuticals, Inc. | 6 | $137 |
| Organogenesis Inc. | 4 | $85 |
| Melinta Therapeutics, LLC | 5 | $70 |
| Johnson & Johnson(2 entities) | 2 | $45 |
| Biowound Solutions, Inc. | 1 | $20 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$940 in reported general payments places this provider in the 55th percentile of 30 podiatrist providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $732 |
| Doxycycline Hyclate | 29 | $710 |
| Pregabalin | 15 | $676 |
| Diclofenac Sodium | 49 | $429 |
| Terbinafine Hcl | 42 | $380 |
| Cephalexin | 40 | $332 |
| Gabapentin | 28 | $165 |
| Meloxicam | 74 | $140 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in McPherson
- David BlanchoGalena$193K
- Jeffrey RoithOverland Park$69K
- Matthew GallianoOverland Park$19K
- Thomas TruongWichita$11K
- Jennifer PhillipsOverland Park$3K
- Nhi leLenexa$3K
- Henry GoppertTopeka$3K
- Nicholas PosgeEl Dorado$3K
- Kirsten PaulsrudHutchinson$2K
- Frank GalbraithWichita$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.